Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen

被引:167
作者
Rao, K [1 ]
Amrolia, PJ [1 ]
Jones, A [1 ]
Cale, CM [1 ]
Naik, P [1 ]
King, D [1 ]
Davies, GE [1 ]
Gaspar, HB [1 ]
Veys, PA [1 ]
机构
[1] Great Ormond St Hosp Children, London WC1N 3JH, England
关键词
D O I
10.1182/blood-2004-03-0960
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The optimal approach to stem cell transplantation in children with immunodeficiency who lack a matched family donor is controversial. Unrelated donor stem cell transplantation gives equivalent outcome to mismatched family donor stem cell transplantation in severe combined immunodeficiency, whereas unrelated donors may be preferable in non-severe combined immunodeficiency children. However, unrelated donor stem cell transplantation with conventional conditioning regimens has been associated with significant treatment-related toxicity, particularly in non-severe combined immunodeficiency patients with preexisting organ dysfunction. We report the outcome of a series of 33 consecutive unrelated donor transplantations performed at our center in children with primary immunodeficiency using a reduced-intensity conditioning regimen between 1998 and 2001. We have compared these outcomes with a retrospective control cohort of 19 patients who underwent transplantation with myeloablative conditioning between 1994 and 1998. All children in both groups had primary engraftment. There was no statistical difference in the speed of immune reconstitution or incidence of graft-versus-host disease between the 2 groups. Overall survival was significantly better in the reduced-intensity conditioning group: 31 (94%) of 33 patients survived. compared with 10 (53%) of 19 in the myeloablative conditioning group (P = .014). We conclude that the reduced-intensity conditioning regimen results in improved survival and reduced transplantation-related mortality compared with myeloablative conditioning in high-risk patients undergoing unrelated donor transplantation. (C) 2005 by The American Society of Hematology.
引用
收藏
页码:879 / 885
页数:7
相关论文
共 27 条
[1]   Nonmyeloablative stem cell transplantation for congenital immunodeficiencies [J].
Amrolia, P ;
Gaspar, HB ;
Hassan, A ;
Webb, D ;
Jones, A ;
Sturt, N ;
Mieli-Vergani, G ;
Pagliuca, A ;
Mufti, G ;
Hadzic, N ;
Davies, G ;
Veys, P .
BLOOD, 2000, 96 (04) :1239-1246
[2]   Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99 [J].
Antoine, C ;
Müller, S ;
Cant, A ;
Cavazzana-Calvo, M ;
Veys, P ;
Vossen, J ;
Fasth, A ;
Heilmann, C ;
Wulffraat, N ;
Seger, R ;
Blanche, S ;
Friedrich, W ;
Abinun, M ;
Davies, G ;
Bredius, R ;
Schulz, A ;
Landais, P ;
Fischer, A .
LANCET, 2003, 361 (9357) :553-560
[3]   Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency [J].
Buckley, RH ;
Schiff, SE ;
Schiff, RI ;
Markert, ML ;
Williams, LW ;
Roberts, JL ;
Myers, LA ;
Ward, FE .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (07) :508-516
[4]  
BUCKLEY RH, 1986, J IMMUNOL, V136, P2398
[5]   Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: Where do we go from here? [J].
Chakrabarti, S ;
Hale, G ;
Waldmann, H .
TRANSPLANTATION PROCEEDINGS, 2004, 36 (05) :1225-1227
[6]   High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution [J].
Chakrabarti, S ;
Mackinnon, S ;
Chopra, R ;
Kottaridis, PD ;
Peggs, K ;
O'Gorman, P ;
Chakraverty, R ;
Marshall, T ;
Osman, H ;
Mahendra, P ;
Craddock, C ;
Waldmann, H ;
Hale, G ;
Fegan, CD ;
Yong, K ;
Goldstone, AH ;
Linch, DC ;
Milligan, DW .
BLOOD, 2002, 99 (12) :4357-4363
[7]   Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses [J].
Childs, R ;
Clave, E ;
Contentin, N ;
Jayasekera, D ;
Hensel, N ;
Leitman, S ;
Read, EJ ;
Carter, C ;
Bahceci, E ;
Young, NS ;
Barrett, AJ .
BLOOD, 1999, 94 (09) :3234-3241
[8]   Immunophenotyping of blood lymphocytes in childhood - Reference values for lymphocyte subpopulations [J].
ComansBitter, WM ;
deGroot, R ;
vandenBeemd, R ;
Neijens, HJ ;
Hop, WCJ ;
Groeneveld, K ;
Hooijkaas, H ;
vanDongen, JJM .
JOURNAL OF PEDIATRICS, 1997, 130 (03) :388-393
[9]   Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 trial [J].
De Rossi, A ;
Walker, AS ;
Klein, N ;
De Forni, D ;
King, D ;
Gibb, DM .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (03) :312-320
[10]   Changes in thymic function with age and during the treatment of HIV infection [J].
Douek, DC ;
McFarland, RD ;
Keiser, PH ;
Gage, EA ;
Massey, JM ;
Haynes, BF ;
Polis, MA ;
Haase, AT ;
Feinberg, MB ;
Sullivan, JL ;
Jamieson, BD ;
Zack, JA ;
Picker, LJ ;
Koup, RA .
NATURE, 1998, 396 (6712) :690-695